This study aims to conduct a meta-analysis to explore the safety of different Trop2 ADCs in advanced breast cancer, and to compare the efficacy of Trop2 ADCs in advanced HR+/HER2- and triple-negative breast cancer using a network meta-analysis.
Trop2 ADC在晚期乳腺癌中的安全性与疗效分析
本文通过Meta分析和网络Meta分析，探讨Trop2 ADC在晚期乳腺癌中的安全性，并比较其在HR+/HER2-和三阴性乳腺癌中的疗效，依据2025最新治疗指南提供临床建议。
与梅斯小智对话
